Company Profile
Amgen Ventures is the corporate venture capital arm of Amgen Inc., a global biotechnology leader dedicated to discovering, developing, and delivering innovative human therapeutics. Founded to support and collaborate with emerging companies in the life sciences space, Amgen Ventures focuses on early-stage investments that align with Amgen’s scientific and strategic priorities.
The firm invests in startups that are pioneering novel therapies, platform technologies, and digital health solutions, with a strong emphasis on therapeutic areas such as oncology, inflammation, neuroscience, and cardiovascular diseases. Amgen Ventures brings more than funding—it offers strategic support, access to Amgen’s extensive scientific resources, and potential for long-term partnership opportunities.
With a portfolio of promising biotech companies across North America and beyond, Amgen Ventures plays a critical role in fostering external innovation. The team operates with a collaborative mindset, helping startups advance their science while complementing Amgen’s mission to serve patients with serious illnesses.
News & Signals (0)
No linked news activity found for this company.